NM_000152.5(GAA):c.-32-13T>G AND Glycogen storage disease, type IV

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Aug 19, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002288463.3

Allele description [Variation Report for NM_000152.5(GAA):c.-32-13T>G]

NM_000152.5(GAA):c.-32-13T>G

Gene:

GAA:alpha glucosidase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17q25.3

Genomic location:

Preferred name:

NM_000152.5(GAA):c.-32-13T>G

Other names:

IVS1-13T>G

HGVS:

NC_000017.11:g.80104542T>G
NG_009822.1:g.7987T>G
NM_000152.5:c.-32-13T>GMANE SELECT
NM_001079803.3:c.-32-13T>G
NM_001079804.3:c.-32-13T>G
LRG_673t1:c.-32-13T>G
LRG_673:g.7987T>G
NC_000017.10:g.78078341T>G
NM_000152.3:c.-32-13T>G
NM_000152.4:c.-32-13T>G
NM_001079803.1:c.-32-13T>G
NM_001079804.3:c.-32-13T>G

Nucleotide change:

IVS1AS, T-G, -13

Links:

OMIM: 606800.0006; dbSNP: rs386834236

NCBI 1000 Genomes Browser:

rs386834236

Molecular consequence:

NM_000152.5:c.-32-13T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001079803.3:c.-32-13T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001079804.3:c.-32-13T>G - intron variant - [Sequence Ontology: SO:0001627]

Functional consequence:

Unknown function
unknown functional consequence

Observations:

Condition(s)

Name:: Glycogen storage disease, type IV (GSD4)
Synonyms:: AMYLOPECTINOSIS; ANDERSEN DISEASE; BRANCHER DEFICIENCY; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0009292; MedGen: C0017923; Orphanet: 367; OMIM: 232500

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002581250	MGZ Medical Genetics Center	criteria provided, single submitter (ACMG Guidelines, 2015)	Pathogenic (Aug 19, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002581250

MGZ Medical Genetics Center

criteria provided, single submitter

(ACMG Guidelines, 2015)

Pathogenic
(Aug 19, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	10	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From MGZ Medical Genetics Center, SCV002581250.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	10	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		10	not provided	not provided	not provided

Last Updated: Jan 13, 2025

ClinVar

Relating variation to medicine